Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nilanjan Chatterjee

Showing results (201-210 of 401) with videos related to

Pageof 41
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 25, 2007
Functional variant of manganese superoxide dismutase (SOD2 V16A) polymorphism is associated with prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer studyDaehee Kang, Kyoung-Mu Lee, Sue Kyung Park, et al.
Cancer Research|May 13, 2010
Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascadeIdan Menashe, Dennis Maeder, Montserrat Garcia-Closas, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 2, 2009
Serum retinol and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trialJeannette M Schenk, Elio Riboli, Nilanjan Chatterjee, et al.
International Journal of Cancer|January 4, 2008
Endogenous sex hormones and the risk of prostate cancer: a prospective studyJocelyn M Weiss, Wen-Yi Huang, Sabina Rinaldi, et al.
Journal of the National Cancer Institute|February 16, 2006
Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer riskVictoria A Kirsh, Richard B Hayes, Susan T Mayne, et al.
BMC Medical Genetics|February 3, 2009
SLC6A3 and body mass index in the Prostate, Lung, Colorectal and Ovarian Cancer Screening TrialElizabeth M Azzato, Lindsay M Morton, Andrew W Bergen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 26, 2005
Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenomaWen-Yi Huang, Nilanjan Chatterjee, Stephen Chanock, et al.
International Journal of Cancer|April 18, 2007
Risk of human T-lymphotropic virus type I-associated diseases in Jamaica with common HLA typesJames J Goedert, Hong-Chuan Li, Xiao-Jiang Gao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2010
Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasiaJames V Lacey, Mark E Sherman, Brenda B Rush, et al.
American Journal of Human Genetics|August 8, 2020
Combined Utility of 25 Disease and Risk Factor Polygenic Risk Scores for Stratifying Risk of All-Cause MortalityAllison Meisner, Prosenjit Kundu, Yan Dora Zhang, et al.
Pageof 41

Showing results (201-210 of 401) with videos related to

Sort By:
Pageof 41
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 25, 2007
Functional variant of manganese superoxide dismutase (SOD2 V16A) polymorphism is associated with prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer studyDaehee Kang, Kyoung-Mu Lee, Sue Kyung Park, et al.
Cancer Research|May 13, 2010
Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascadeIdan Menashe, Dennis Maeder, Montserrat Garcia-Closas, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 2, 2009
Serum retinol and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trialJeannette M Schenk, Elio Riboli, Nilanjan Chatterjee, et al.
International Journal of Cancer|January 4, 2008
Endogenous sex hormones and the risk of prostate cancer: a prospective studyJocelyn M Weiss, Wen-Yi Huang, Sabina Rinaldi, et al.
Journal of the National Cancer Institute|February 16, 2006
Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer riskVictoria A Kirsh, Richard B Hayes, Susan T Mayne, et al.
BMC Medical Genetics|February 3, 2009
SLC6A3 and body mass index in the Prostate, Lung, Colorectal and Ovarian Cancer Screening TrialElizabeth M Azzato, Lindsay M Morton, Andrew W Bergen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 26, 2005
Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenomaWen-Yi Huang, Nilanjan Chatterjee, Stephen Chanock, et al.
International Journal of Cancer|April 18, 2007
Risk of human T-lymphotropic virus type I-associated diseases in Jamaica with common HLA typesJames J Goedert, Hong-Chuan Li, Xiao-Jiang Gao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2010
Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasiaJames V Lacey, Mark E Sherman, Brenda B Rush, et al.
American Journal of Human Genetics|August 8, 2020
Combined Utility of 25 Disease and Risk Factor Polygenic Risk Scores for Stratifying Risk of All-Cause MortalityAllison Meisner, Prosenjit Kundu, Yan Dora Zhang, et al.
Pageof 41